All In Biotech

Drug Trial Radar · NCT00223977

2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.

A Multi-center, Randomized, Open Label Study of the Efficacy and Safety of Two Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peroneal Dialysis Patients Receiving Erythropoietin.

Last checked: Nov 20, 2026Latest source record: Jul 8, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 146 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

146

Actual

Start

Dec 2003

Primary completion

Nov 2004

Study completion Feb 2008

Sponsor

Lead sponsor
Watson PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Sep 22, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase 3 clinical investigation. Patients who meet the eligibility criteria and provide signed informed consent will be randomized to receive one of two levels of Ferrlecit or oral iron in a 1:1:1 ratio.

Conditions

  • Iron Deficiency Anemia

Interventions

  • Sodium Ferric Gluconate ComplexDrug

    125 mg weekly x 8 weeks

  • Sodium Ferric Gluconate ComplexDrug

    250 mg weekly x 4

  • Oral IronDrug

    325 mg ferrous sulfate orally three times daily x 8 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. HemoglobinTime frame: Baseline to 5 weeks and 9 weeks

Locations

43 sites in 8 countries. Site status is shown where the registry gives one.

  • Site not named

    Birmingham, Alabama

  • Site not named

    Mesa, Arizona

  • Site not named

    Los Angeles, California

  • Site not named

    Torrance, California

  • Site not named

    New Haven, Connecticut

  • Site not named

    Evanston, Illinois

  • Site not named

    Shreveport, Louisiana

  • Site not named

    Springfield, Massachusetts

  • Site not named

    Worcester, Massachusetts

  • Site not named

    Royal Oak, Michigan

  • Site not named

    St Louis, Missouri

  • Site not named

    New York, New York

  • Site not named

    Chapel Hill, North Carolina

  • Site not named

    Winston-Salem, North Carolina

  • Site not named

    Tulsa, Oklahoma

  • Site not named

    Philadelphia, Pennsylvania

  • Site not named

    Sioux Falls, South Dakota

  • Site not named

    Dallas, Texas

  • Site not named

    Richmond, Virginia

  • Site not named

    Sofia, Bulgaria

  • Site not named

    Varna, Bulgaria

  • Site not named

    Kelowna, Canada

  • Site not named

    Kitchener, Canada

  • Site not named

    London, Canada

  • Site not named

    Scarborough, Canada

  • Site not named

    Toronto, Canada

  • Site not named

    Zagreb, Croatia

  • Site not named

    Bangalore, India

  • Site not named

    Chandigarh, India

  • Site not named

    Chennai, India

  • Site not named

    Hyderabad, India

  • Site not named

    Lucknow, India

  • Site not named

    Mahīm, India

  • Site not named

    New Delhi, India

  • Site not named

    Col. Toriello Guerra, Mexico

  • Site not named

    Durango, Mexico

  • Site not named

    Mexico City, Mexico

  • Site not named

    Monterrey, Mexico

  • Site not named

    Tlalpan, Mexico

  • Site not named

    Zapopan, Mexico

Showing 40 of 43 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.